Blinatumomab Archives - Medical Conferences

New standard-of-care for paediatric B-cell ALL

Presented By

Dr Rachel Rau, University of Washington, WA, USA

Trial

Phase 3, AALL1731

Conference

ASH 2024

Type

Peer-reviewed article

29 January 2025 09:57

Blinatumomab reduces toxicity in the consolidation phase in paediatric high-risk B-cell ALL

Presented By

Prof. Martin Schrappe, Hong Kong College of Paediatricians, China

Trial

Phase 3, AIEOP-BFM ALL 2017

Conference

ASH 2023

Type

Peer-reviewed article

7 February 2024 15:02

Blinatumomab may improve outcomes in patients with B-cell ALL undergoing ASCT

Presented By

Dr Ayman Sayyed, University of Toronto, Canada

Conference

EBMT 2023

Type

Peer-reviewed article

14 June 2023 20:02

Blinatumomab candidate for standard-of-care in newly diagnosed B-ALL

Presented By

Prof. Mark Litzow, Mayo Clinic, MN, USA

Trial

Phase 3, ECOG-ACRIN-E1910 NCTN

Conference

ASH 2022

Type

Peer-reviewed article

20 February 2023 11:07

New Interfant protocol includes blinatumomab for KMT2A-r ALL

Presented By

Dr Inge van der Sluis, Princess Máxima Center for Pediatric Oncology, the Netherlands

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 12:00

Likely new standard of care: Blinatumomab for children with relapsed B-ALL

Presented By

Prof. Patrick A. Brown, Johns Hopkins Kimmel Cancer Center, Baltimore, USA

Trial

Phase 3, AALL1331

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 23:15